PURPOSE: Many cancer clinical trials lack appropriate representation of specific patient populations, limiting their generalizability. Therefore, we determined the representation of ethnic minorities and women in cancer clinical trials. METHODS: Enrollment data from all therapeutic trials reported as completed in ClinicalTrials.gov from 2003 to 2016 were analyzed. We calculated enrollment fractions (EFs) for each group, defined as the number of enrollees divided by the 2013 Surveillance, Epidemiology, and End Results (SEER) database cancer prevalence. RESULTS: Of 1,012 clinical trials, 310 (31%) reported ethnicity with a total of 55,689 enrollees. Participation varied significantly across ethnic groups. Non-Hispanic whites were more likely to be enrolled in clinical trials (EF, 1.2%) than African Americans (EF, 0.7%; P < .001) and Hispanics (EF, 0.4%; P < .001). A decrease in African American (6% v 9.2%) and Hispanic (2.6% v 3.1%) enrollment was observed when compared with historical data from 1996 to 2002. Younger patients (age younger than 65 years) were more likely to be enrolled in clinical trials than the elderly (64% v 36%; P < .001). Low recruitment of female patients was observed in clinical trials for melanoma (35%), lung cancer (39%), and pancreatic cancer (40%). CONCLUSION: We observed a decrease in recruitment of minorities over the past 14 years compared with historical data. African Americans, Hispanics, and women were less likely to be enrolled in cancer clinical trials. Future trials should take extra measures to recruit participants that adequately represent the US cancer population.
PURPOSE: Many cancer clinical trials lack appropriate representation of specific patient populations, limiting their generalizability. Therefore, we determined the representation of ethnic minorities and women in cancer clinical trials. METHODS: Enrollment data from all therapeutic trials reported as completed in ClinicalTrials.gov from 2003 to 2016 were analyzed. We calculated enrollment fractions (EFs) for each group, defined as the number of enrollees divided by the 2013 Surveillance, Epidemiology, and End Results (SEER) database cancer prevalence. RESULTS: Of 1,012 clinical trials, 310 (31%) reported ethnicity with a total of 55,689 enrollees. Participation varied significantly across ethnic groups. Non-Hispanic whites were more likely to be enrolled in clinical trials (EF, 1.2%) than African Americans (EF, 0.7%; P < .001) and Hispanics (EF, 0.4%; P < .001). A decrease in African American (6% v 9.2%) and Hispanic (2.6% v 3.1%) enrollment was observed when compared with historical data from 1996 to 2002. Younger patients (age younger than 65 years) were more likely to be enrolled in clinical trials than the elderly (64% v 36%; P < .001). Low recruitment of female patients was observed in clinical trials for melanoma (35%), lung cancer (39%), and pancreatic cancer (40%). CONCLUSION: We observed a decrease in recruitment of minorities over the past 14 years compared with historical data. African Americans, Hispanics, and women were less likely to be enrolled in cancer clinical trials. Future trials should take extra measures to recruit participants that adequately represent the US cancer population.
Authors: Joycelyn Cudjoe; Ruth-Alma Turkson-Ocran; Angelica K Ezeigwe; Yvonne Commodore-Mensah; Manka Nkimbeng; Hae-Ra Han Journal: J Community Health Date: 2019-10
Authors: Susan R Passmore; Amelia M Jamison; Moaz Abdelwadoud; Taylor B Rogers; Morgan Wiggan; Daniel C Mullins; Stephen B Thomas Journal: Field methods Date: 2020-12-30
Authors: Emily M Rencsok; Latifa A Bazzi; Rana R McKay; Franklin W Huang; Adam Friedant; Jake Vinson; Samuel Peisch; Jelani C Zarif; Stacey Simmons; Kelly Hawthorne; Paul Villanti; Philip W Kantoff; Elisabeth Heath; Daniel J George; Lorelei A Mucci Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-06-05 Impact factor: 4.254
Authors: H Evin Gulbahce; Philip S Bernard; Erin K Weltzien; Rachel E Factor; Lawrence H Kushi; Bette J Caan; Carol Sweeney Journal: Cancer Date: 2018-10-12 Impact factor: 6.860
Authors: Margaret M Lubas; Yan Lu; Aaron W Gehr; Bassam Ghabach; Bhavna Tanna; Kalyani Narra; Tara M Brinkman; Rohit P Ojha Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-11-18 Impact factor: 4.254
Authors: Samilia Obeng-Gyasi; Sheetal M Kircher; Kelsey P Lipking; Benjamin J Keele; Al B Benson; Lynne I Wagner; Ruth C Carlos Journal: Cancer Date: 2019-06-28 Impact factor: 6.860
Authors: Susan Racine Passmore; Amelia M Jamison; Gregory R Hancock; Moaz Abdelwadoud; C Daniel Mullins; Taylor B Rogers; Stephen B Thomas Journal: Public Health Genomics Date: 2020-01-17 Impact factor: 2.000